GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » EV-to-Revenue

Access Bio (XKRX:950130) EV-to-Revenue : -0.46 (As of May. 28, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Access Bio's enterprise value is ₩-64,429 Mil. Access Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩139,453 Mil. Therefore, Access Bio's EV-to-Revenue for today is -0.46.

The historical rank and industry rank for Access Bio's EV-to-Revenue or its related term are showing as below:

XKRX:950130' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.59   Med: 4.05   Max: 24.7
Current: -0.46

During the past 12 years, the highest EV-to-Revenue of Access Bio was 24.70. The lowest was -0.59. And the median was 4.05.

XKRX:950130's EV-to-Revenue is ranked better than
98.2% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.21 vs XKRX:950130: -0.46

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Access Bio's stock price is ₩6880.00. Access Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩3,997.85. Therefore, Access Bio's PS Ratio for today is 1.72.


Access Bio EV-to-Revenue Historical Data

The historical data trend for Access Bio's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio EV-to-Revenue Chart

Access Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.34 6.44 0.88 - 0.09

Access Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.37 -0.36 0.17 0.09 -0.30

Competitive Comparison of Access Bio's EV-to-Revenue

For the Diagnostics & Research subindustry, Access Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Access Bio's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Access Bio's EV-to-Revenue falls into.



Access Bio EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Access Bio's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-64428.736/139453.198
=-0.46

Access Bio's current Enterprise Value is ₩-64,429 Mil.
Access Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩139,453 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Access Bio  (XKRX:950130) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Access Bio's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6880.00/3997.846
=1.72

Access Bio's share price for today is ₩6880.00.
Access Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,997.85.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Access Bio EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Access Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Access Bio (XKRX:950130) Business Description

Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines